Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions-Reference-Cited by-同舟云学术

Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions

Published:2020-01 Issue: Volume:142 Page:105122
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Nicolas Jean-Marie^ORCID,Chanteux Hugues,Nicolaï Johan,Brouta Frédéric,Viot Delphine,Rosseels Marie-Luce,Gillent Eric,Bonnaillie Pierre,Mathy François-Xavier,Long Jeff,Helmer Eric

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference75 articles.

1. Seletalisib: characterization of a novel, potent, and selective inhibitor of PI3Kdelta;Allen;J. Pharmacol. Exp. Ther.,2017

2. Loperamide: a pharmacological review;Baker;Rev. Gastroenterol. Disord.,2007

3. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice;Barraud de Lagerie;Br. J. Pharmacol.,2004

4. Imaging P-Glycoprotein function at the blood-brain barrier as a determinant of the variability in response to central nervous system drugs;Bauer;Clin. Pharmacol. Ther.,2019

5. Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.;Bauer;Br. J. Clin. Pharmacol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and Optimization of P-Glycoprotein- Rich Lipid Raft Chromatography;2023

2. In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals;Pharmaceutics;2022-08-18

3. EBV associated T‐ and NK‐cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights;Reviews in Medical Virology;2022-02-04